Login

Joseph Chen, CEO of Renren Inc., discusses the Chinese social-networking site's recent $855 million completion. 00:10:00

Share On Facebook Share On Twitter

Joseph Chen and Chen Ji are the CEOs of Renren.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
F&C Investment Trust | Insights from Tom Joy, Independent Non-Executive Director
00:10:00
Julie Van Kleeck, Vice President for Advanced Space and Launch at Aerojet Rocketdyne, discusses the company's extensive rocket engine portfolio and technological advancements in propulsion systems​|Ms. Eileen P. Drake has served as Chief Executive Officer
00:10:00
The Future of Fintech|Hans Morris,Managing Partner,Nyca Partners
00:10:00
Galan Lithium Limited: Strategic Projects and Future Outlook at the One-to-One Mining Investment Conference in London
00:10:00
The Future of Investment DAOs |Vic Singh,Co-Founder,Eniac Ventures
00:10:00
Investment Partners were formerly with predecessor firm SV Investment Partners|NICHOLAS SOMERS, Managing Partner,SV Investment Partners
00:00:00
Forward looking statements about Cyclacel Pharmaceuticals, Inc. - Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, Inc.
00:10:00
Resolute Mining's Automation Journey at Syama Gold Mine: Enhancing Safety and Efficiency in Mali
00:10:00
Charles Gordon, Head of Investor Relations at Hochschild Mining PLC provides insights into recent developments of the Peru-based gold and silver miner in the #OTCQX Video Series.|Eduardo Hochschild Chairman of Hochschild Mining PLC
00:10:00
Graham is poised to become only the 4th CEO in Softcat's history later in 2023.
00:10:00
Unveiling the Philippines' Largest REIT: Insights from Jericho Go and Kerwin Max Tan | Jericho Go, CEO, RL Commercial REIT.
00:10:00
Envisioning 2030: The Transformative Impact of Privatization and Vouchers on American Education

© 2017 - Neuhu+